Kayoko Matsumoto Selected Research

cefditoren pivoxil (Spectracef)

2/2014	Population pharmacokinetics of cefditoren pivoxil in non-infected adults.
2/2014	Prediction of clinical bacteriological efficacy of oral antibiotics using a mechanism-based pharmacokinetic-pharmacodynamics modeling.
12/2013	Population pharmacokinetic analysis of cefditoren pivoxil in pediatric patients with infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kayoko Matsumoto Research Topics

Disease

2	Infections 02/2014 - 12/2013
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 06/2007 - 10/2006
1	Leukemia 11/2021
1	Otitis Media 02/2014
1	Body Weight (Weight, Body) 02/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2006
1	Carcinoma (Carcinomatosis) 10/2006
1	Adenocarcinoma 10/2006
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 10/2004
1	Parkinson Disease (Parkinson's Disease) 03/2003
1	Melanoma (Melanoma, Malignant) 02/2003

Drug/Important Bio-Agent (IBA)

3	cefditoren pivoxil (Spectracef)FDA Link 02/2014 - 12/2013
2	Messenger RNA (mRNA)IBA 06/2007 - 10/2006
1	HLA-DPB1 antigen (HLA DPB1)IBA 11/2021
1	CreatinineIBA 02/2014
1	Pharmaceutical PreparationsIBA 02/2014
1	Homeodomain Proteins (Proteins, Homeobox)IBA 10/2004
1	ElementsIBA 10/2004
1	Proteins (Proteins, Gene)FDA Link 10/2004
1	Transcription Factors (Transcription Factor)IBA 10/2004
1	salicylhydroxamic acid (SHAM)IBA 03/2003
1	linderol AIBA 02/2003
1	benzofuranIBA 02/2003
1	Melanins (Melanin)IBA 02/2003
1	dimethylsulfoxonium methylideIBA 02/2003

Therapy/Procedure

1	Oral Administration 02/2014